Abdallah Elnwasany
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdallah Elnwasany has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Luke I. Szweda
Department of Internal Medicine (Cardiology) (D.D., S.D.G., A.A., H.I.M., N.J., C.I.I., A.F., V.G.-M., N.N., L.M.-R., D.D.Z., F.O.-S., G.C., F.W., B.A.R., L.I.S., S.L., T.G.G., J.A.H.), UT Southwestern Medical Center, Dallas, TX
3 shared publications Alisson C. Cardoso
Department of Internal Medicine and Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center, Dallas (W.M.E., A.C.C., A.H.M.P., A.E., S.E., Y.N., H.A.S.).
1 shared publicationAna Helena M. Pereira
Department of Internal Medicine and Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center, Dallas (W.M.E., A.C.C., A.H.M.P., A.E., S.E., Y.N., H.A.S.).
1 shared publicationCaroline S. Kinter
From the Aging and Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104
1 shared publicationCatherine A. Makarewich
The Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, and
1 shared publicationChristopher Schafer
From the Aging and Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104
1 shared publication
Latest Publications
- Open Access
- 26 February 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (6) , 723-733
In vivo assessment of the recovery of myocardial pyruvate dehydrogenase activity following a ketogenic diet
Aims: A ketogenic diet (KD) can suppress cardiac carbohydrate utilization, which may adversely impact heart function. However, the reversibility of KD-induced metabolic changes is poorly understood. This study aims to characterize myocardial pyruvate dehydrogenase (PDH) flux during the transition from a prolonged KD to a normal chow diet (ND). Methods and results: Cardiac metabolism was longitudinally assessed in rats using hyperpolarized [1-13C]pyruvate at baseline, during a KD (2 and 5 weeks), and a subsequent ND (1, 2, 5, and 8 days) after the 5-week KD. Hyperpolarized 13C products were compared between the KD group and age-matched ND controls. In parallel, nuclear magnetic resonance isotopomer analysis of cardiac tissue with an injection of [3-13C]pyruvate and [1,2-13C2]acetate was performed along with ex vivo enzymatic analysis of PDH activity. Myocardial [13C]bicarbonate production relative to total 13C products decreased from 8.56 ± 2.29% at baseline to 0.46 ± 0.27% after 5 weeks of KD. Reverting to ND gradually restored PDH flux (8.40 ± 1.47% by Day 8) to control levels (8.69 ± 2.10%). Ex vivo NMR analysis of glutamate C4 showed reduced pyruvate contribution to acetyl-CoA during KD (4.1 ± 2.5%), which recovered upon reverting to ND (22.7 ± 1.82% vs. control: 27.6 ± 9.5%). Although PDK4 expression normalized, PDH activity remained partially impaired in the reverted group (36.80 ± 6.07 mmol NADH/min/mg) compared to controls (90.97 ± 5.40; P = 0.00007). Conclusion: KD-induced suppression of myocardial PDH flux is reversible, but its recovery requires significant time, with prolonged metabolic inflexibility persisting after transitioning to an ND. These findings highlight the value of in vivo assessment of cardiac PDH activity, complemented by conventional enzymatic analyses, to identify persistent metabolic inflexibility following ketogenic interventions.
- 26 February 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (6) , 723-733
Open AccessIn vivo assessment of the recovery of myocardial pyruvate dehydrogenase activity following a ketogenic diet
Aims: A ketogenic diet (KD) can suppress cardiac carbohydrate utilization, which may adversely impact heart function. However, the reversibility of KD-induced metabolic changes is poorly understood. This study aims to characterize myocardial pyruvate dehydrogenase (PDH) flux during the transition from a prolonged KD to a normal chow diet (ND). Methods and results: Cardiac metabolism was longitudinally assessed in rats using hyperpolarized [1-13C]pyruvate at baseline, during a KD (2 and 5 weeks), and a subsequent ND (1, 2, 5, and 8 days) after the 5-week KD. Hyperpolarized 13C products were compared between the KD group and age-matched ND controls. In parallel, nuclear magnetic resonance isotopomer analysis of cardiac tissue with an injection of [3-13C]pyruvate and [1,2-13C2]acetate was performed along with ex vivo enzymatic analysis of PDH activity. Myocardial [13C]bicarbonate production relative to total 13C products decreased from 8.56 ± 2.29% at baseline to 0.46 ± 0.27% after 5 weeks of KD. Reverting to ND gradually restored PDH flux (8.40 ± 1.47% by Day 8) to control levels (8.69 ± 2.10%). Ex vivo NMR analysis of glutamate C4 showed reduced pyruvate contribution to acetyl-CoA during KD (4.1 ± 2.5%), which recovered upon reverting to ND (22.7 ± 1.82% vs. control: 27.6 ± 9.5%). Although PDK4 expression normalized, PDH activity remained partially impaired in the reverted group (36.80 ± 6.07 mmol NADH/min/mg) compared to controls (90.97 ± 5.40; P = 0.00007). Conclusion: KD-induced suppression of myocardial PDH flux is reversible, but its recovery requires significant time, with prolonged metabolic inflexibility persisting after transitioning to an ND. These findings highlight the value of in vivo assessment of cardiac PDH activity, complemented by conventional enzymatic analyses, to identify persistent metabolic inflexibility following ketogenic interventions.
- Open Access
- 20 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 756
Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy
Obesity affects a growing fraction of the population and is a risk factor for type 2 diabetes and cardiovascular disease. Even in the absence of hypertension and coronary artery disease, type 2 diabetes can result in a heart disease termed diabetic cardiomyopathy. Diminished glucose oxidation, increased reliance on fatty acid oxidation for energy production, and oxidative stress are believed to play causal roles. However, the progression of metabolic changes and mechanisms by which these changes impact the heart have not been established. Cardiac pyruvate dehydrogenase (PDH), the central regulatory site for glucose oxidation, is rapidly inhibited in mice fed high dietary fat, a model of obesity and diabetes. Increased reliance on fatty acid oxidation for energy production, in turn, enhances mitochondrial pro-oxidant production. Inhibition of PDH may therefore initiate metabolic inflexibility and oxidative stress and precipitate diabetic cardiomyopathy. We discuss evidence from the literature that supports a role for PDH inhibition in loss in energy homeostasis and diastolic function in obese and diabetic humans and in rodent models. Finally, seemingly contradictory findings highlight the complexity of the disease and the need to delineate progressive changes in cardiac metabolism, the impact on myocardial structure and function, and the ability to intercede.
- 20 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 756
Open AccessInhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy
Obesity affects a growing fraction of the population and is a risk factor for type 2 diabetes and cardiovascular disease. Even in the absence of hypertension and coronary artery disease, type 2 diabetes can result in a heart disease termed diabetic cardiomyopathy. Diminished glucose oxidation, increased reliance on fatty acid oxidation for energy production, and oxidative stress are believed to play causal roles. However, the progression of metabolic changes and mechanisms by which these changes impact the heart have not been established. Cardiac pyruvate dehydrogenase (PDH), the central regulatory site for glucose oxidation, is rapidly inhibited in mice fed high dietary fat, a model of obesity and diabetes. Increased reliance on fatty acid oxidation for energy production, in turn, enhances mitochondrial pro-oxidant production. Inhibition of PDH may therefore initiate metabolic inflexibility and oxidative stress and precipitate diabetic cardiomyopathy. We discuss evidence from the literature that supports a role for PDH inhibition in loss in energy homeostasis and diastolic function in obese and diabetic humans and in rodent models. Finally, seemingly contradictory findings highlight the complexity of the disease and the need to delineate progressive changes in cardiac metabolism, the impact on myocardial structure and function, and the ability to intercede.
- 22 January 2019
- Published by Wolters Kluwer Health in Circulation
- Vol. 139 (4) , 559-561
C-Kit Cells Do Not Significantly Contribute to Cardiomyogenesis During Neonatal Heart Regeneration
- 22 January 2019
- Published by Wolters Kluwer Health in Circulation
- Vol. 139 (4) , 559-561
C-Kit Cells Do Not Significantly Contribute to Cardiomyogenesis During Neonatal Heart Regeneration
- Open Access
- 1 May 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (18) , 6915-6924
Coenzyme A–mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice
- 1 May 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (18) , 6915-6924
Open AccessCoenzyme A–mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice